www.finanzen.net bietet Finanznachrichten zum weltweiten BörsengeschehenFinanzenhttps://www.finanzen.netde-definanzen.net GmbHWed, 08 Jul 2026 19:39:58 +0200https://images.finanzen.net/images/finanzen_net_neu.gifhttps://www.finanzen.netWed, 01 Jul 2026 15:04:41 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-continued-u-s-government-investment-in-orthopox-preparedness-as-strategic-validation-of-long-term-vaccine-readiness-15775283

EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-continued-u-s-government-investment-in-orthopox-preparedness-as-strategic-validation-of-long-term-vaccine-readiness-15775283Wed, 17 Jun 2026 15:03:41 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-strategic-implications-of-recent-gedeptin-r-findings-for-checkpoint-resistant-cancers-15749992 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Highlights Strategic Implications of Recent Gedeptin(R) Findings for Checkpoint-Resistant Cancers 17.06.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-strategic-implications-of-recent-gedeptin-r-findings-for-checkpoint-resistant-cancers-15749992Mon, 08 Jun 2026 15:03:21 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-peer-reviewed-research-supporting-gedeptin-r-potential-to-enhance-cancer-immunotherapy-responses-15733398 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Highlights Peer-Reviewed Research Supporting Gedeptin(R) Potential to Enhance Cancer Immunotherapy Responses 08.06.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-peer-reviewed-research-supporting-gedeptin-r-potential-to-enhance-cancer-immunotherapy-responses-15733398Wed, 03 Jun 2026 15:06:01 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-ceo-highlights-renewed-strategic-interest-in-vaccine-platforms-and-infectious-disease-innovation-15726033 EQS-News: GeoVax, Inc. / Key word(s): Science GeoVax CEO Highlights Renewed Strategic Interest in Vaccine Platforms and Infectious Disease Innovation 03.06.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-ceo-highlights-renewed-strategic-interest-in-vaccine-platforms-and-infectious-disease-innovation-15726033Mon, 01 Jun 2026 15:20:21 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-ceo-welcomes-fifa-world-cup-2026-while-addressing-biothreat-readiness-15721421 EQS-News: GeoVax, Inc. / Key word(s): Science GeoVax CEO Welcomes FIFA World Cup 2026 While Addressing Biothreat Readiness 01.06.2026 / 15:20 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-ceo-welcomes-fifa-world-cup-2026-while-addressing-biothreat-readiness-15721421Wed, 27 May 2026 15:03:32 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-registration-now-open-for-tribe-public-ceo-presentation-and-q-amp-amp-a-webinar-event-15711804 EQS-News: GeoVax, Inc. / Key word(s): Financial Registration Now Open for Tribe Public CEO Presentation and Qamp;amp;A Webinar Event 27.05.2026 / 15:03 CET/CEST The ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-registration-now-open-for-tribe-public-ceo-presentation-and-q-amp-amp-a-webinar-event-15711804Tue, 26 May 2026 13:35:41 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-accelerates-focus-on-geo-mva-commercialization-and-advancement-of-oncology-program-gedeptin-r-15709380 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Accelerates Focus on GEO-MVA Commercialization and Advancement of Oncology Program Gedeptin(R) 26.05.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-accelerates-focus-on-geo-mva-commercialization-and-advancement-of-oncology-program-gedeptin-r-15709380Wed, 20 May 2026 16:06:01 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-comments-on-escalating-bundibugyo-ebola-outbreak-and-growing-need-for-flexible-biodefense-vaccine-platforms-15699958 EQS-News: GeoVax, Inc. / Key word(s): Science GeoVax Comments on Escalating Bundibugyo Ebola Outbreak and Growing Need for Flexible Biodefense Vaccine Platforms 20.05.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-comments-on-escalating-bundibugyo-ebola-outbreak-and-growing-need-for-flexible-biodefense-vaccine-platforms-15699958Mon, 18 May 2026 20:33:41 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-strategic-importance-of-domestic-mva-based-preparedness-infrastructure-amid-escalating-global-infectious-disease-threats-15696090 EQS-News: GeoVax, Inc. / Key word(s): Science GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-highlights-strategic-importance-of-domestic-mva-based-preparedness-infrastructure-amid-escalating-global-infectious-disease-threats-15696090Thu, 14 May 2026 22:05:11 +0200https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-reports-first-quarter-2026-financial-results-and-highlights-geo-mva-phase-3-trial-implementation-plans-15686344 EQS-News: GeoVax, Inc. / Key word(s): Financial GeoVax Reports First Quarter 2026 Financial Results and Highlights GEO-MVA Phase 3 Trial Implementation Plans 14.05.2026 ... ]]>https://www.finanzen.net/nachricht/aktien/eqs-news-geovax-reports-first-quarter-2026-financial-results-and-highlights-geo-mva-phase-3-trial-implementation-plans-15686344